How Custom Trial Tech Empowers Mid-Sized Biotechs to Scale Research

Introduction: The CRO Gap for Emerging Biotechs

For mid-sized biotechs and scale-ups, advancing clinical research often comes with a tough reality: the major CRO platforms were not built for you. While large pharmaceutical sponsors benefit from one-size-fits-all enterprise systems, emerging biotechs face rigid tools, misaligned service models, and ballooning costs that don’t reflect their stage or agility.

In the race to bring therapies to market, startups and growth-stage biotechs need technology that is as nimble, adaptive, and lean as they are—not generic trial tech built for Big Pharma's playbook. That’s where a tailored approach changes everything.

The Challenge: Underserved by Traditional Clinical Platforms

Startups and mid-sized biotechs often face these core hurdles with traditional CRO-aligned technology:

• Overbuilt, Under-Configurable Systems: Legacy eClinical platforms can be cumbersome and slow to deploy, with inflexible workflows.

• Cost-Prohibitive Licensing and Support: Pricing models assume large volumes and long commitments—misaligned with biotechs running a few strategic studies.

• Slow, Siloed Support Models: CROs prioritize high-revenue accounts, often putting smaller sponsors at the back of the queue.

• Limited Data Interoperability: Integrating with EHRs, ePROs, labs, or wearable tech often requires costly middleware or is not supported at all.

These limitations stifle the very thing that biotech innovators need: speed, precision, and the freedom to iterate.

The Solution: Custom Trial Tech Built for Biotech Scale-Ups

At Touchcore Systems, we specialize in custom-fit clinical research technology—designed not around a one-size-fits-all mold, but around your science, your trial footprint, and your growth stage.

Here’s how we enable mid-sized sponsors to scale confidently:

1. Modular Platforms, Rapid Deployment

We develop lightweight, modular systems—EDC, eConsent, ePRO, CTMS, dashboards—that go live in weeks, not quarters. Each module is tailored to your specific protocol and data flow.

2. Flexible Data Integration

Whether you’re working with real-world data, decentralized trial inputs, or exploratory biomarkers, we ensure seamless data ingestion and visualization pipelines that don’t require manual cleanup or CRO intermediaries.

3. Affordable Customization

We eliminate bloat and focus on value. Our pricing scales with your needs, not with outdated assumptions of volume-based trials. No costly licenses. No tech debt.

4. Biotech-Centric Collaboration

Our team partners closely with your ops, biometrics, and clinical leads to iterate fast—whether that’s adapting dashboards mid-trial or enabling remote monitoring at short notice.

Why This Matters Now?

As more mid-sized sponsors drive first-in-human and adaptive trials, clinical operations are becoming a strategic differentiator. The ability to act on real-time insights, customize data flows, and avoid rigid tech bottlenecks can dramatically accelerate milestones—and investor confidence.

You don’t have to wait until you’re a large sponsor to have clinical technology that’s purpose-built. You can have it now—with the right partner.

Ready to Scale Smarter?

At Touchcore, we’re helping emerging biotechs own their clinical research stack. Whether you’re preparing for your first IND or running multi-site trials globally, let’s build a trial tech foundation that grows with you—not against you.

📩 Reach out to us at partner@touchcoresystems.com explore how we can help you scale clinical operations on your terms.